Table 4.

Survival analysis: time from randomization to first CV hospitalization in intensive care/coronary care unit during the study period

	Placebo (n = 2327)	Dronedarone (n = 2301)
Number of events	270 (11.6%)	218 (9.5%)
Cumulative incidence of events (95% CI)
At 6 months	0.057 (0.047–0.066)	0.041 (0.033–0.050)
At 1 year	0.082 (0.071–0.094)	0.068 (0.058–0.079)
At 2 years	0.127 (0.112–0.142)	0.107 (0.093–0.121)
Log-rank test P value	0.0174
HR (95% CI)a	0.806 (0.674–0.963)

^aDetermined from Cox regression model.